background preloader

Viral Load Quantification in HIV-1 and HCMV

Viral Load Quantification in HIV-1 and HCMV
Abstract Viral load quantification is the amount of particular viral DNA or RNA in a blood samples. It is one of the surrogate biomarker of AIDS. Citation Information Mahendra Kumar Trivedi. Related:  mikeandersonmrickysmithrs

Burkholderia Cepacia Antimicrobial Susceptibility Testing An Effect of Biofield Treatment on Multidrug-resistant Burkholderia cepacia: A Multihost Pathogen Mahendra Kumar Trivedi , Shrikant Patil , Harish Shettigar , Mayank Gangwar , Snehasis Jana Trivedi Global Inc., 10624 S Eastern Avenue Suite A-969, Henderson, NV 89052, USA Trivedi Science Research Laboratory Pvt. Corresponding author: Snehasis Jana, Trivedi Science Research Laboratory Pvt. 462026, Madhya Pradesh, India, Tel: +91-755-6660006; E-mail: publication@trivedisrl.com Rec date: Jun 29, 2015, Acc date: Jul 10, 2015, Pub date: Jul 17, 2015 Copyright: © 2015 Jana S et al. distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Burkholderia cepacia (B. cepacia) is an opportunistic, Gram negative pathogen which causes infection mainly in immunocompromised population and associated with high rate of morbidity and mortality in cystic fibrosis patients. sample of B. cepacia was divided into two groups i.e. control and biofield treated. tazobactam.

Antimicrobial Susceptibility Testing of Burkholderia Cepacia Abstract Burkholderia cepacia (B. cepacia) is an opportunistic, Gram negative pathogen which causes infection mainly in immunocompromised population and associated with high rate of morbidity and mortality in cystic fibrosis patients. Aim of the present study was to analyze the impact of biofield treatment on multidrug resistant B. cepacia. Clinical sample of B. cepacia was divided into two groups i.e. control and biofield treated. The analysis was done after 10 days of treatment and compared with control group. Citation Information Mahendra Kumar Trivedi. DNA Polymorphism of Nocardia otitidis & Biofield Treatment Citation: Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, et al. (2015) Evaluation of Antibiogram, Genotype and Phylogenetic Analysis of Bioeld Treated Nocardia otitidis. Biol Syst Open Access 4: 143. doi:10.4172/2329-6577.1000143 Page 2 of 6 Volume 4 • Issue 2 • 1000143 Biol Syst Open Access ISSN: 2329-6577 BSO, an open access journal Ampere’s law, which states that the moving charge produces magnetic elds in the surrounding space [15,16]. electromagnetic waves in the form of bio-photons that is also known as ultra-weak photon emissions (UPE). is commonly known as bioeld. electromagnetic eld, being generated by moving electrically charged particles (ions, cell, molecule, etc.) inside the human body [17]. transfer of information from cell to cell or DNA or storage by biophotons has been demonstrated in plants, bacteria, animal neutriophil granulocytes and kidney cells [18]. various scientic instruments such as Kirlian photography, polycontrast the Globe. bioeld energy treatment. kit.

Antibiogram, Phylogenetic & Genotype Analysis Nocardia Otitidis Title: Evaluation of Antibiogram, Genotype and Phylogenetic Analysis of Biofield Treated Nocardia otitidis Publication: Biological Systems: Open Access Select license: Creative Commons Attributions-NonCommercial-ShareAlike Updated: November 21st, 2016 Abstract: Nocardiosis is a soil-borne aerobic infection caused by Nocardia species commonly affects the respiratory tract.

Effect of Biofield Energy Treatment on Streptococcus group B: A Postpartum Pathogen Citation: Trivedi MK, Branton A, Trivedi D, Nayak G, Shettigar H, et al. (2015) Effect of Bioeld Energy Treatment on Streptococcus group B: A Postpartum Pathogen. J Microb Biochem Technol 7: 269-273. doi:10.4172/1948-5948.1000223 Volume 7(5): 269-273 (2015) - 270 J Microb Biochem Technol ISSN: 1948-5948 JMBT, an open access journal bioeld treatment that is also called as Trivedi eect . unique bioeld treatment has been known to transform the structural, physical, and thermal properties of several metals in material science [12-14], improved the overall productivity of crops [15,16], altered characteristics features of microbes [17-19] and improved growth and anatomical characteristics of various medicinal plants [20,21]. Due to the clinical signicance of this organism and literature reports on bioeld treatment, the present work was undertaken to evaluate the impact of bioeld treatment on S. agalactiae group B in relation to antimicrobials susceptibility and bio typing based on (Dade Behring

Alteration of Gr.II Streptococcus Agalactiae Biotype Number Abstract Streptococcus agalactiae group B (S. agalactiae gr. B) is widespread in nature mainly causes bacterial septicemia and neonatal meningitis. The current study was attempted to investigate the effect of biofield treatment on S. agalactiae gr. B with respect of antimicrobial sensitivity, biochemical reactions and bio typing. S. agalactiae gr. Citation Information Mahendra Kumar Trivedi.

Analysis of Multidrug Resistant S.Maltophilia Abstract Stenotrophomonas maltophilia ( S. maltophilia ) is a Gram-negative bacillus, an opportunistic pathogen, particularly among nosocomial infections. Multi-drug resistant strains are associated with very high rate of morbidity and mortality in severely immunocompromised patients. Present study was designed to evaluate the effect of biofield treatment against multidrug resistant S. maltophilia . Keywords: Stenotrophomonas maltophilia ; Multidrug resistant; Antimicrobial susceptibility; Biofield treatment; Biochemical reactions; Biotyping Introduction During the last few decades, due to the continuous deployment of antimicrobial drugs, incidence of microbial resistance has increased leads to generating multi-drug-resistance (MDR) organisms (MDROs). Now a days, acceptance and applications of complementary and alternative therapies are at global level. There are very few reports on biofield treatment against sensitivity pattern of MDROs. Evaluation of antimicrobial susceptibility assay

Study of Streptococcus Agalactiae Characteristics Alterations Citation: Trivedi MK, Branton A, Trivedi D, Nayak G, Shettigar H, et al. (2015) Effect of Bioeld Energy Treatment on Streptococcus group B: A Postpartum Pathogen. J Microb Biochem Technol 7: 269-273. doi:10.4172/1948-5948.1000223 Volume 7(5): 269-273 (2015) - 270 J Microb Biochem Technol ISSN: 1948-5948 JMBT, an open access journal bioeld treatment that is also called as Trivedi eect®. unique bioeld treatment has been known to transform the structural, physical, and thermal properties of several metals in material science [12-14], improved the overall productivity of crops [15,16], altered characteristics features of microbes [17-19] and improved growth and anatomical characteristics of various medicinal plants [20,21]. Due to the clinical signicance of this organism and literature reports on bioeld treatment, the present work was undertaken to evaluate the impact of bioeld treatment on S. agalactiae group B in relation to antimicrobials susceptibility and bio typing based on (Gr.). e Gr.

Potential Impact of Biofield on HIV Viral Load Test Abstract Viral load quantification is the amount of particular viral DNA or RNA in a blood samples. It is one of the surrogate biomarker of AIDS. Keywords: Human Immune Deficiency Virus, Biofield Treatment, Cytomegalo Virus, Viral Load, HIV RNA, HCMV DNAaemia, AIDS, Surrogate Biomarker 1. Human immunodeficiency virus type 1 (HIV-1) is the main causative agent of acquired immune deficiency syndrome (AIDS) [1]. 2. The viral samples (HIV-1 and HCMV) as stored stock cultures were procured from department of microbiology laboratory, P.D. 2.1. Two sets of each viral samples (HIV-1; 31 samples and HCMV; 5 samples) of HIV and HCMV infected stored plasma were used in this experiment for determination of viral load quantification. 2.2. The COBAS® amplicor HIV-1 monitor test (v1.5) is an in vitro nucleic acid amplification test approved by food and drug administration (FDA) for the quantification of HIV-1 RNA in human plasma on the COBAS AMPLICORTM analyzer. 2.3. 3. Figure 1. Figure 2. Figure 3.

Related: